Article Listing - InSite prepares NDA on AzaSite

FORTHCOMING MEETINGS FROM IBC

13 April 1992

IBC Technical Services Ltd is organizing the following industry-related conferences over the next few months:

- Strategies, Costs and Timing: The...

FRENCH HEALTH SPENDING RISE

13 April 1992

French health care spending by the CNAM insurance fund rose 0.3% between December 1991 and January 1992. Spending in January...

US NEW PRESCRIPTI0N DRUG SALES IN 1991

13 April 1992

The leading new prescription pharmaceutical product in the USA last year was Wyeth-Ayerst's non-steroidal anti-inflammatory drug Lodine (etodolac), which received...

BEIERSDORF SEES SALES AND PROFIT UP

13 April 1992

Profits at the north German drugs group Beiersdorf AG have incr-eased at an above-average rate in relation to good sales...

ROCHE CONSOLIDATED PROFIT LEAPS 56% IN 1991

13 April 1992

For 1991, Swiss pharmaceutical major Hoffmann-La Roche reported "continued and significant improvement in the group's earning performance," with consolidated group...

CHINESE MEDICAL SCIENCE VILLAGE

13 April 1992

A "medical science village" has started operation in Zhuhai in the Chinese province of Guangdong. The village covers an area...

ORGANON LAUNCHES PHYSIOGINE IN FRANCE

13 April 1992

Organon has launched Physiogine (estriol), in 0.1% vaginal cream and 0.5mg capsule formulations for the local treatment of post-menopausal symptoms,...

ABBOTT 1st QTR NET EARNINGS LEAP 16%

13 April 1992

For the first quarter of 1992, US-based Abbott Laboratories recorded a 15.8% jump in net earnings to $294 million, on...

GYNEX TO MARKET DELATESTRYL

13 April 1992

Gynex Pharma has acquired US marketing rights to Bristol-Myers Squibb's Delatestryl (testosterone) as a treatment for male hypogonadism and delayed...

LEON JOINS RESEARCHLIFE

13 April 1992

Alberta Leon has joined Italian R&D company Researchlife following her resignation as chief executive officer at Fidia.